common.study.topics.clinical

New Strategy to Predict Early Sepsis

common.study.values.description

New Strategy to Predict Early Sepsis

This is an observational prospective multicentre study on patients attending the emergency department and suspected to have sepsis. Blood markers characteristic of a Cellular Reprogramming (CR) signature and predicting severe sepsis and organ failure will be measured and validated.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Blood sample collection

A blood sample (1 tube) will be collected for the analysis of the CR signature.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Development of a New Strategy to Predict Early Sepsis

common.study.values.clinical-trial-id

NCT04118179

participant.views.study.view.id

aM8rAe